MAPT and Alzheimer disease: A study in a mouse model of AD shows a reduction in the activity of biliverdin reductase-A, an enzyme that participates in cell growth, which was triggered by oxidative stress, which precedes the accumulation of Aβ, tau pathology, and the elevation of TNF-α.